| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $271.9M | +11.5% |
| Cost of Revenue | $138.9M | +9.5% |
| Gross Profit | $132.9M | +13.6% |
| R&D Expense | $189.4M | +18.5% |
| SG&A Expense | $97.4M | -1.8% |
| Operating Income | -$254.2M | -37.2% |
| Pre-tax Income | -$221.0M | -20.3% |
| Income Tax | -$3.5M | — |
| Net Income | -$217.5M | -18.4% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $553.2M | — |
| Accounts Receivable | $3.4M | +36.2% |
| Inventory | $10.8M | +72.9% |
| Current Assets | $601.8M | — |
| Total Assets | $1.15B | +126.3% |
| Current Liabilities | $153.2M | +26.0% |
| Total Liabilities | $236.4M | +268.7% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$166.8M | -124.7% |
| Capital Expenditures | $4.0M | -2.1% |
| Investing Cash Flow | -$108.1M | -1554.5% |
| Financing Cash Flow | $546.0M | +251.5% |
| Free Cash Flow | -$170.8M | -118.1% |
| Stockholders' Equity |
| $915.7M |
| — |